{"id":492,"date":"2020-01-07T10:15:55","date_gmt":"2020-01-07T10:15:55","guid":{"rendered":"http:\/\/events.marketsandmarkets.com\/blog\/?p=492"},"modified":"2020-01-07T10:15:55","modified_gmt":"2020-01-07T10:15:55","slug":"speaker-interview-with-fabio-dagostino-for-4th-annual-marketsandmarkets-bioprocessing-of-advanced-cellular-therapies-regenerative-medicine-congress","status":"publish","type":"post","link":"https:\/\/events.marketsandmarkets.com\/blognew\/speaker-interview-with-fabio-dagostino-for-4th-annual-marketsandmarkets-bioprocessing-of-advanced-cellular-therapies-regenerative-medicine-congress\/","title":{"rendered":"Speaker Interview with Fabio D&#8217;Agostino for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies &#038; Regenerative Medicine Congress"},"content":{"rendered":"\n<p><strong>London, January 07<\/strong> \u2013 MarketsandMarkets interviewed <strong>Fabio D&#8217;Agostino<\/strong>,Venture Partner, Claris Ventures regarding 4th Annual <strong>MarketsandMarkets Bioprocessing of Advanced Cellular Therapies &amp; Regenerative Medicine Congress<\/strong> taking place on 10-11 March 2020 in London \u2013 UK. \u00a0 <\/p>\n\n\n\n<p><strong>Q. What is the most trending areas of cellular therapies currently?\u00a0\u200b<\/strong><\/p>\n\n\n\n<p><strong>A.<\/strong> CART and NK cell<\/p>\n\n\n\n<p><strong>Q. What are the recent developments and technological advancements?\u00a0<\/strong><\/p>\n\n\n\n<p><strong>A<\/strong>. CART for solid tumors and NK CAR\u00a0<\/p>\n\n\n\n<p><strong>Q. What are the key take away points from your presentation?\u00a0\u200b<\/strong><\/p>\n\n\n\n<p>A. They are basically summarized in my bullet points. I will show what are the elements investors look in a cell therapy development program and why manufacturing is important<\/p>\n\n\n\n<p><strong>Q. At which platforms the bioprocessing and advanced therapies community is most active?\u00a0\u200b<\/strong><\/p>\n\n\n\n<p>A. The most important platforms are the ones for automated closed manufacturing of cell therapies<\/p>\n\n\n\n<p><strong>Q. Feedback on Agenda<\/strong><\/p>\n\n\n\n<p>A. It looks an interesting program and agenda ?<\/p>\n\n\n\n<p>The latest conference agenda and complete speaker line-up is available to download on the conference page, where you can also register \u2013&nbsp;<a href=\"https:\/\/bit.ly\/2qKzuSC\" target=\"_blank\" rel=\"noopener\"><strong>https:\/\/bit.ly\/2qKzuSC<\/strong><\/a><\/p>\n\n\n\n<ul class=\"is-layout-flex wp-block-gallery-1 wp-block-gallery columns-1 is-cropped\"><li class=\"blocks-gallery-item\"><figure><img loading=\"lazy\" width=\"600\" height=\"170\" src=\"http:\/\/events.marketsandmarkets.com\/blog\/wp-content\/uploads\/2019\/12\/4th-BACT_600x170.jpg\" alt=\"https:\/\/events.marketsandmarkets.com\/4th-annual-marketsandmarkets-bioprocessing-of-advanced-cellular-therapies-regenerative-medicine-congress\/\" data-id=\"484\" data-link=\"http:\/\/events.marketsandmarkets.com\/blog\/speaker-interview-with-petter-bjorquist-for-4th-annual-marketsandmarkets-bioprocessing-of-advanced-cellular-therapies-regenerative-medicine-congress\/4th-bact_600x170\/\" class=\"wp-image-484\" srcset=\"https:\/\/events.marketsandmarkets.com\/blognew\/wp-content\/uploads\/2019\/12\/4th-BACT_600x170.jpg 600w, https:\/\/events.marketsandmarkets.com\/blognew\/wp-content\/uploads\/2019\/12\/4th-BACT_600x170-200x57.jpg 200w\" sizes=\"(max-width: 600px) 100vw, 600px\" \/><\/figure><\/li><\/ul>\n\n\n\n<p>For more inquiries contact Suraj Waghmare, Marketing Executive on&nbsp;<strong><a href=\"http:\/\/suraj.waghmare@marketsandmarkets.com\/\">suraj.waghmare@marketsandmarkets.com<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>London, January 07 \u2013 MarketsandMarkets interviewed Fabio D&#8217;Agostino,Venture Partner, Claris Ventures regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies &amp; Regenerative Medicine Congress taking place on 10-11 March 2020 in London \u2013 UK. \u00a0 Q. What is the most trending areas of cellular therapies currently?\u00a0\u200b A. CART and NK cell Q. What are the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":493,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_mi_skip_tracking":false},"categories":[3,5,2,1],"tags":[189,178,78,143,188],"_links":{"self":[{"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/posts\/492"}],"collection":[{"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/comments?post=492"}],"version-history":[{"count":1,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/posts\/492\/revisions"}],"predecessor-version":[{"id":494,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/posts\/492\/revisions\/494"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/media\/493"}],"wp:attachment":[{"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/media?parent=492"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/categories?post=492"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/tags?post=492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}